These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31138658)

  • 1. A Model of Hereditary Sensory and Autonomic Neuropathy Type 1 Reveals a Role of Glycosphingolipids in Neuronal Polarity.
    Cui M; Ying R; Jiang X; Li G; Zhang X; Zheng J; Tam KY; Liang B; Shi A; Göbel V; Zhang H
    J Neurosci; 2019 Jul; 39(29):5816-5834. PubMed ID: 31138658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of dietary alanine toxicity and trafficking dysfunction in a Drosophila model of hereditary sensory and autonomic neuropathy type 1.
    Oswald MC; West RJ; Lloyd-Evans E; Sweeney ST
    Hum Mol Genet; 2015 Dec; 24(24):6899-909. PubMed ID: 26395456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the wild-type SPT1 subunit lowers desoxysphingolipid levels and rescues the phenotype of HSAN1.
    Eichler FS; Hornemann T; McCampbell A; Kuljis D; Penno A; Vardeh D; Tamrazian E; Garofalo K; Lee HJ; Kini L; Selig M; Frosch M; Gable K; von Eckardstein A; Woolf CJ; Guan G; Harmon JM; Dunn TM; Brown RH
    J Neurosci; 2009 Nov; 29(46):14646-51. PubMed ID: 19923297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Variant (Asn177Asp) in SPTLC2 Causing Hereditary Sensory Autonomic Neuropathy Type 1C.
    Suriyanarayanan S; Othman A; Dräger B; Schirmacher A; Young P; Mulahasanovic L; Hörtnagel K; Biskup S; von Eckardstein A; Hornemann T; Lone MA
    Neuromolecular Med; 2019 Jun; 21(2):182-191. PubMed ID: 30955194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1.
    Hines TJ; Tadenev ALD; Lone MA; Hatton CL; Bagasrawala I; Stum MG; Miers KE; Hornemann T; Burgess RW
    J Anat; 2022 Nov; 241(5):1169-1185. PubMed ID: 34875719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSAN1 mutations in serine palmitoyltransferase reveal a close structure-function-phenotype relationship.
    Bode H; Bourquin F; Suriyanarayanan S; Wei Y; Alecu I; Othman A; Von Eckardstein A; Hornemann T
    Hum Mol Genet; 2016 Mar; 25(5):853-65. PubMed ID: 26681808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.
    Penno A; Reilly MM; Houlden H; Laurá M; Rentsch K; Niederkofler V; Stoeckli ET; Nicholson G; Eichler F; Brown RH; von Eckardstein A; Hornemann T
    J Biol Chem; 2010 Apr; 285(15):11178-87. PubMed ID: 20097765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in vivo and confers an age-dependent neuropathy.
    McCampbell A; Truong D; Broom DC; Allchorne A; Gable K; Cutler RG; Mattson MP; Woolf CJ; Frosch MP; Harmon JM; Dunn TM; Brown RH
    Hum Mol Genet; 2005 Nov; 14(22):3507-21. PubMed ID: 16210380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1.
    Garofalo K; Penno A; Schmidt BP; Lee HJ; Frosch MP; von Eckardstein A; Brown RH; Hornemann T; Eichler FS
    J Clin Invest; 2011 Dec; 121(12):4735-45. PubMed ID: 22045570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.
    Gantner ML; Eade K; Wallace M; Handzlik MK; Fallon R; Trombley J; Bonelli R; Giles S; Harkins-Perry S; Heeren TFC; Sauer L; Ideguchi Y; Baldini M; Scheppke L; Dorrell MI; Kitano M; Hart BJ; Cai C; Nagasaki T; Badur MG; Okada M; Woods SM; Egan C; Gillies M; Guymer R; Eichler F; Bahlo M; Fruttiger M; Allikmets R; Bernstein PS; Metallo CM; Friedlander M
    N Engl J Med; 2019 Oct; 381(15):1422-1433. PubMed ID: 31509666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and Molecular Characterization of New
    Rochat J; Blavier A; Ruet S; Vasseur S; Puma A; Desnous B; Chan V; Delmont E; Attarian S; Juntas Morales R; Quadrio I; Vidoni L; Bonello-Palot N; Cheillan D
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts.
    Karsai G; Steiner R; Kaech A; Lone MA; von Eckardstein A; Hornemann T
    J Lipid Res; 2021; 62():100122. PubMed ID: 34563520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family.
    Wilson LMQ; Saba S; Li J; Prasov L; Miller JML
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis.
    Bejaoui K; Uchida Y; Yasuda S; Ho M; Nishijima M; Brown RH; Holleran WM; Hanada K
    J Clin Invest; 2002 Nov; 110(9):1301-8. PubMed ID: 12417569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pyridoxal 5'-phosphate (PLP)-dependent enzyme serine palmitoyltransferase (SPT): effects of the small subunits and insights from bacterial mimics of human hLCB2a HSAN1 mutations.
    Beattie AE; Gupta SD; Frankova L; Kazlauskaite A; Harmon JM; Dunn TM; Campopiano DJ
    Biomed Res Int; 2013; 2013():194371. PubMed ID: 24175284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Variant p.(Arg183Trp) in SPTLC2 Causes Late-Onset Hereditary Sensory Neuropathy.
    Suriyanarayanan S; Auranen M; Toppila J; Paetau A; Shcherbii M; Palin E; Wei Y; Lohioja T; Schlotter-Weigel B; Schön U; Abicht A; Rautenstrauss B; Tyynismaa H; Walter MC; Hornemann T; Ylikallio E
    Neuromolecular Med; 2016 Mar; 18(1):81-90. PubMed ID: 26573920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I.
    Dawkins JL; Hulme DJ; Brahmbhatt SB; Auer-Grumbach M; Nicholson GA
    Nat Genet; 2001 Mar; 27(3):309-12. PubMed ID: 11242114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated.
    Hornemann T; Penno A; Richard S; Nicholson G; van Dijk FS; Rotthier A; Timmerman V; von Eckardstein A
    Neurogenetics; 2009 Apr; 10(2):135-43. PubMed ID: 19132419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
    Lone MA; Aaltonen MJ; Zidell A; Pedro HF; Morales Saute JA; Mathew S; Mohassel P; Bönnemann CG; Shoubridge EA; Hornemann T
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine Palmitoyltransferase (SPT)-related Neurodegenerative and Neurodevelopmental Disorders.
    Mohassel P; Abdullah M; Eichler FS; Dunn TM
    J Neuromuscul Dis; 2024; 11(4):735-747. PubMed ID: 38788085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.